The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Selective Destruction of Stable Microtubules and Axons by Inhibitors of Protein Serine/Threonine Phosphatases in Cultured Human Neurons (NT2N Cells)
Open accessAbstract
Paired helical filaments (PHFs) in the neurofibrillary tangles (NFTs) in Alzheimer’s disease (AD) brains are composed of highly phosphorylated isoforms of tau (PHFtau) that fail to bind microtubules (MTs), and the levels of MT-binding competent tau are decreased in AD brains with abundant PHFtau. Because this loss of MT binding could compromise the viability of tangle-bearing AD neurons by destabilizing MTs, we asked whether these events could be initiated by inhibiting protein phosphatase 1 (PP1) and PP2A in cultured human neurons (NT2N cells) using okadaic acid (OK) and calyculin-A (CL-A). The treatment of NT2N cells with OK and CL-A increased tau phosphorylation, decreased the binding of tau to MTs, and selectively depolymerized the more stable detyrosinated MTs but not the more labile tyrosinated MTs. Significantly, this led to the rapid degeneration of axons, which are enriched in the more stable detyrosinated MTs, and PP2A was implicated in the initiation of this cascade of events because PP2A but not PP1 was closely associated with MTs in the NT2N cells. These studies imply that inactivation of PP2A in vulnerable neurons of the AD brain may play a mechanistic role in the conversion of normal tau into PHFtau, in the depolymerization of stable MTs, and in the degeneration of axons emanating from tangle-bearing neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, under pathological conditions, various highly increased post-translational modifications, such as hyperphosphorylation, destabilize the interaction of tau with microtubules [33] and enhance the capacity of tau to accumulate in the cytoplasm [34], leading to microtubule instability and transport dysfunction.”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Bialojan, C., & Takai, A. (1988) · Biochemical Journal · doi:10.1042/bj2560283 · Cited by 1,689
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 6×
“Two phosphate-dependent anti-tau antibodies that recognize PHFtau also used were the T3P antiserum (Lee et al., 1991) and the PHF1 mAb, which was kindly provided by Dr. P. Davies (Albert Einstein College of Medicine) (Greenberg et al., 1992; Otvos et al., 1994).”
BackgroundMethodInfluentialSelf-citationOkadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,373
Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity
Ishihara, H., Martin, B. L., Brautigan, D. L., Karaki, H., Ozaki, H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K., Uemura, D., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92189-x · Cited by 1,044
Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line.
Kilmartin, J. V., Wright, B., & Milstein, C. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.93.3.576 · Cited by 942
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citationPhosphorylation affects the ability of tau protein to promote microtubule assembly.
Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901
Research works printed but not linked: 2
- Andrews, 1984, Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line NTera-2., Lab Invest, 50, 147
- Goslin K Banker G (1991) Rat hippocampal neurons in low-density culture. in Culturing nerve cells, eds Banker G Goslin K (MIT, Cambridge).
Cited by
Sorted by citations
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Self-citationJanssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles
Guo, J. L., & Lee, V. M.-Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209296 · Cited by 636
Self-citationTau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516
“However, under pathological conditions, various highly increased post-translational modifications, such as hyperphosphorylation, destabilize the interaction of tau with microtubules [33] and enhance the capacity of tau to accumulate in the cytoplasm [34], leading to microtubule instability and transport dysfunction.”
BackgroundAdvances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2959 · Cited by 440
Self-citationMicrotubules and signal transduction
Gundersen, G. G., & Cook, T. A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80010-6 · Cited by 407
Protein phosphatase 2A: the Trojan Horse of cellular signaling
Sontag, E. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00123-6 · Cited by 330
Brunden, K. R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J. S., Hogan, A.-M. L., Iba, M., James, M. J., Xie, S. X., Ballatore, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3059-10.2010 · Cited by 320
Self-citationMolecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules
Sontag, E., Nunbhakdi‐Craig, V., Lee, G. S., Brandt, R., Kamibayashi, C., Kuret, J., White, C. L., Mumby, M. C., & Bloom, G. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25490 · Cited by 305
Okadaic Acid: More than a Diarrheic Toxin
Valdiglesias, V., Prego-Faraldo, M. V., Pásaro, E., Méndez, J., & Laffón, B. (2013) · Marine Drugs · doi:10.3390/md11114328 · Cited by 283
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
Brandt, R., Hundelt, M., & Shahani, N. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.018 · Cited by 235
Clodfelder‐Miller, B., Zmijewska, A. A., Johnson, G. V. W., & Jope, R. S. (2006) · Diabetes · doi:10.2337/db06-0485 · Cited by 187
Sun, L., Liu, S. Y., Zhou, X. W., Wang, X. C., Liu, R., Wang, Q., & Wang, J. Z. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00697-8 · Cited by 168
Rundén‐Pran, E., Seglen, P. O., Haug, F. Š., Ottersen, O. P., Wieloch, T. W., Shamloo, M., & Laake, J. H. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07296.1998 · Cited by 167
Brunden, K. R., Yao, Y., Potuzak, J. S., Ferrer, N. I., Ballatore, C., James, M. J., Hogan, A. L., Trojanowski, J. Q., Smith, A. B., & Lee, V. M. ‐. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.002 · Cited by 159
Self-citationNeurofilament protein synthesis and phosphorylation
Grant, P. G., & Pant, H. C. (2000) · Journal of Neurocytology · doi:10.1023/a:1010999509251 · Cited by 158
Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus
Zhang, C.-E., Tian, Q., Wei, W., Peng, J.-H., Liu, G., Zhou, X., Wang, Q., Wang, D. W., & Wang, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.015 · Cited by 159
Ittner, L. M., Ke, Y. D., & Götz, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014472 · Cited by 156
Brandt, R., Gergou, A., Wacker, I. U., Fath, T., & Hutter, H. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.011 · Cited by 146
Gene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease
Mufson, E. J., Counts, S., & Ginsberg, S. D. (2002) · Neurochemical Research · doi:10.1023/a:1020952704398 · Cited by 138
Planel, E., Bretteville, A., Liu, L., Virág, L., Du, A. L., Yu, W. H., Dickson, D. W., Whittington, R. A., & Duff, K. (2009) · The FASEB Journal · doi:10.1096/fj.08-122424 · Cited by 138
Cholesterol‐dependent modulation of tau phosphorylation in cultured neurons
Fan, Q., Yu, W., Senda, T., Yanagisawa, K., & Michikawa, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00063.x · Cited by 136
Cholesterol‐dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons
Fan, Q., Yu, W., Gong, J., Zou, K., Sawamura, N., Senda, T., Yanagisawa, K., & Michikawa, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00686.x · Cited by 134
Tau and Axonopathy in Neurodegenerative Disorders
Higuchi, M., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:131 · Cited by 134
Self-citationVafai, S. B., & Stock, J. B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02702-3 · Cited by 129
Detyrosinated (Glu) microtubules are stabilized by an ATP-sensitive plus-end cap
Infante, A. S., Stein, M. S., Zhai, Y., Borisy, G. G., & Gundersen, G. G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.22.3907 · Cited by 127
Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14406 · Cited by 125
Self-citationDeveloping therapeutic approaches to tau, selected kinases, and related neuronal protein targets
Lee, V. M.-Y., Brunden, K. R., Hutton, M., & Trojanowski, J. Q. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006437 · Cited by 122
Self-citationGallo, G., & Letourneau, P. C. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03860.1999 · Cited by 118
Tong, B., Ba, Y., Li, Z., Yang, C., Su, K., Qi, H., Zhang, D., Liu, X., Wu, Y., Chen, Y., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106505 · Cited by 117
Therapeutic strategies for the treatment of tauopathies: Hopes and challenges
Khanna, M. R., Kovalevich, J., Lee, V. M. ‐., Trojanowski, J. Q., & Brunden, K. R. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.006 · Cited by 116
Self-citationBrain protein serine/threonine phosphatases
Price, N. E., & Mumby, M. C. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)80049-x · Cited by 109
Song, X., Hu, J.-F., Chu, S., Zhang, Z., Xu, S., Yuan, Y., Han, N., Liu, Y., Niu, F., He, X., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.051 · Cited by 107
Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
Mufson, E. J., Counts, S., Fahnestock, M. L., & Ginsberg, S. D. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788855 · Cited by 100
Crowe, A., Huang, W., Ballatore, C., Johnson, R. L., Hogan, A. L., Huang, R., Wichterman, J., McCoy, J. G., Huryn, D. M., Auld, D. S., et al. (2009) · Biochemistry · doi:10.1021/bi9006435 · Cited by 104
Self-citationGoedert, M., Satumtira, S., Jakes, R., Smith, M. J., Kamibayashi, C., White, C. L., & Sontag, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752155.x · Cited by 102
Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease
Brunden, K. R., Trojanowski, J. Q., Smith, A. B., Lee, V. M. ‐., & Ballatore, C. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.046 · Cited by 97
Self-citationBrunden, K. R., Ballatore, C., Crowe, A., Smith, Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.031 · Cited by 93
Self-citationTran, H., Sanchez, L., & Brody, D. L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182456aed · Cited by 93
Gilley, J., Seereeram, A., Ando, K., Mosely, S. I. S., Andrews, S., Kerschensteiner, M., Misgeld, T., Brion, J., Anderton, B. H., Hanger, D. P., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.014 · Cited by 94
The slow axonal transport of cytoskeletal proteins
Nixon, R. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80090-2 · Cited by 90
Oikawa, T., Nonaka, T., Terada, M., Tamaoka, A., Hisanaga, S., & Hasegawa, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736355 · Cited by 87
The role of tau in Alzheimer's disease
Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00002-0 · Cited by 85
Self-citationNeural Stem Cells Improve Learning and Memory in Rats with Alzheimer’s Disease
Wu, S., Sasaki, A., Yoshimoto, R. U., Kawahara, Y., Manabe, T., Kataoka, K., Asashima, M., & Yuge, L. (2008) · Pathobiology · doi:10.1159/000124979 · Cited by 84
Strack, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203767200 · Cited by 81
Planel, E., Krishnamurthy, P., Miyasaka, T., Liu, L., Herman, M., Kumar, A., Bretteville, A., Figueroa, H. Y., Haung Yu, W., Whittington, R. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-08.2008 · Cited by 79
Sudo, H., & Baas, P. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq521 · Cited by 77
Perera, S., Holt, M., Mankoo, B. S., & Gautel, M. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.12.024 · Cited by 75
Matsumura, N., Yamazaki, T., & Ihara, Y. (1999) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65420-x · Cited by 81
Goldbaum, O., Oppermann, M., Handschuh, M., Dabir, D. V., Zhang, B., Forman, M. S., Trojanowski, J. Q., Lee, V. M. ‐., & Richter‐Landsberg, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08872.2003 · Cited by 73
Self-citationYoshiyama, Y., Zhang, B., Bruce, J., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10662.2003 · Cited by 72
Self-citationNunbhakdi‐Craig, V., Schüchner, S., Sontag, J., Montgomery, L. G., Pallas, D. C., Juno, C., Mudrak, I., Ogris, E., & Sontag, E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04503.x · Cited by 72
Kim, D., Su, J. H., & Cotman, C. W. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01724-2 · Cited by 72
Lankoff, A., Banasik, A., Obe, G., Deperas-Kamińska, M., Kuzminski, K., Tarczyńska, M., Jurczak, T., & Wójcik, A. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00094-2 · Cited by 69
Kovalevich, J., Cornec, A., Yao, Y., James, M., Crowe, A., Lee, V. M. Y., Trojanowski, J. Q., Smith, A. B., Ballatore, C., & Brunden, K. R. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.231175 · Cited by 66
Self-citationHoffman, A., Taleski, G., & Sontag, E. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.01.005 · Cited by 67
Transcriptome profiling in neurodegenerative disease
Courtney, E., Kornfeld, S., Janitz, K., & Janitz, M. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.08.018 · Cited by 64
Valdiglesias, V., Laffón, B., Pásaro, E., & Méndez, J. (2011) · Journal of Environmental Monitoring · doi:10.1039/c0em00771d · Cited by 60
Sontag, J. M., & Sontag, E. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6300-7 · Cited by 61
Yin, Y., Liu, H., Cong, X.-B., Liu, Z., Wang, Q., Wang, J., & Zhu, L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1272 · Cited by 56
Wei, W., Liu, Y., Zhang, C.-E., Wang, Q., Wei, Z., Mousseau, D. D., Wang, J., Tian, Q., & Liu, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110770 · Cited by 55
Spinocerebellar ataxia type 12
O’Hearn, E., Holmes, S. E., & Margolis, R. L. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00034-6 · Cited by 56
Lu, Y., Li, T., Qureshi, H. Y., Han, D. C., & Paudel, H. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220962 · Cited by 54
Viquez, N. M., Li, C. R., Wairkar, Y. P., & DiAntonio, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1740-06.2006 · Cited by 53
Go or Stop? Divergent Roles of Reelin in Radial Neuronal Migration
Zhao, S., & Frotscher, M. (2010) · The Neuroscientist · doi:10.1177/1073858410367521 · Cited by 53
Makani, V. S., Zhang, B., Han, H., Yao, Y., Lassalas, P., Lou, K., Paterson, I., Lee, V. M. ‐., Trojanowski, J. Q., Ballatore, C., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0378-4 · Cited by 52
Self-citationDas, V., & Miller, J. H. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08084.x · Cited by 49
Kobayashi, N., Reiser, J., Schwarz, K., Sakai, T., Kriz, W., & Mundel, P. H. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180000242 · Cited by 48
Li, S. P., Deng, Y., Wang, X. C., Wang, Y. P., & Wang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00116.x · Cited by 48
Martin, M., Geudens, I., Bruyr, J., Potente, M., Bleuart, A., Lebrun, M., Simonis, N., Deroanne, C., Twizere, J., Soubeyran, P., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.187 · Cited by 48
Neurotoxic and Synaptic Effects of Okadaic Acid, an Inhibitor of Protein Phosphatases
Tapia, R., Peña‐Ortega, F., & Arias, C. (1999) · Neurochemical Research · doi:10.1023/a:1022588808260 · Cited by 47
Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies
Brunden, K. R., Ballatore, C., Lee, V. M. ‐., Smith, A. B., & Trojanowski, J. Q. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120010 · Cited by 46
Self-citationLiolitsa, D. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.3.261 · Cited by 45
Zhang, B., Yao, Y., Cornec, A., Oukoloff, K., James, M. J., Koivula, P. P., Trojanowski, J. Q., Smith, A. B., Lee, V. M. ‐., Ballatore, C., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0291-3 · Cited by 46
Self-citationGoldbaum, O., & Richter‐Landsberg, C. (2002) · Glia · doi:10.1002/glia.10119 · Cited by 44
New insights into genetic and molecular mechanisms of brain degeneration in tauopathies
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00100-9 · Cited by 43
Self-citationRole of Protein Phosphatases in Estrogen-Mediated Neuroprotection
Yi, K. D., Chung, J., Pang, P. S., & Simpkins, J. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1328-05.2005 · Cited by 42
Partial deletion of theMAPTgene: A novel mechanism of FTDP-17
Rovelet‐Lecrux, A., Lecourtois, M., Thomas-Antérion, C., Ber, I. L., Brice, A., Frébourg, T., Hannequin, D., & Campion, D. (2009) · Human Mutation · doi:10.1002/humu.20979 · Cited by 42
Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease
Mufson, E. J., Counts, S., Che, S., & Ginsberg, S. D. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58010-0 · Cited by 40
Yoon, S. Y., Choi, J. E., Yoon, J. H., Huh, J., & Kim, D. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.013 · Cited by 38
Liang, J. L., Tan, L., Zhang, Y., Guo, Z., & Xu, L. (2011) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1100121 · Cited by 37
Inhibition of protein phosphatases impairs the ability of astrocytes to detoxify hydrogen peroxide
Ferrero-Gutiérrez, A., Pérez‐Gómez, A., Novelli, A., & Fernández‐Sánchez, M. T. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.029 · Cited by 34
Chao, C.-C., Ma, Y., & Lee, E. H. Y. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1531-07.2007 · Cited by 35
Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress
Camões, F., Henriques, A. G., Silva, O. A. B. D. C. E., & Silva, E. F. D. C. E. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2003.12.007 · Cited by 34
Romero-Geraldo, R. D. J., García-Lagunas, N., & Hernández-Saavedra, N. Y. (2016) · Marine Environmental Research · doi:10.1016/j.marenvres.2016.07.011 · Cited by 33
AMPK Ameliorates Tau Acetylation and Memory Impairment Through Sirt1
Wang, L., Shi, F.-X., Li, N., Cao, Y., Lei, Y., Wang, J., Tian, Q., & Zhou, X. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02079-x · Cited by 34
Protein Aggregation in Alzheimers Disease and Other Neoropathological Disorders
Dimakopoulos, A. C. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772795 · Cited by 33
An anchoring factor targets protein phosphatase 2A to brain microtubules
Price, N. E., Wadzinski, B. E., & Mumby, M. C. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00237-5 · Cited by 32
Bcl-2 protects against apoptosis-related microtubule alterations in neuronal cells
Nuydens, R., Dispersyn, G., Kieboom, G. V. D., de Jong, M., Connors, R., Ramaekers, F. C. S., Borgers, M. J., & Geerts, H. (2000) · APOPTOSIS · doi:10.1023/a:1009685609275 · Cited by 31
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation
Fonzo, A. D., Ronchi, D., Gallia, F., Cribiù, F. M., Trezzi, I., Vetro, A., Mina, E. D., Limongelli, I., Bellazzi, R., Ricca, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000476 · Cited by 29
Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases
Koss, D. J., Hindley, K. P., Riedel, G., & Platt, B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04579.x · Cited by 28
Silverstein, A. M., Davis, A. J., Bielinski, V. A., Esplin, E. D., Mahmood, N. A., & Mumby, M. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00168-6 · Cited by 28
Peña‐Ortega, F., Robles-Gómez, Á. A., & Cueva, L. X. (2022) · Cells · doi:10.3390/cells11060923 · Cited by 31
Regulation of PP2A, PP4, and PP6 holoenzyme assembly by carboxyl-terminal methylation
Lyons, S. P., Greiner, E. C., Cressey, L. E., Adamo, M. E., & Kettenbach, A. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-02456-z · Cited by 27
Valdiglesias, V., Fernandez-Tajes, J. J., Pásaro, E., Méndez, J., & Laffón, B. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-46 · Cited by 27
Ren, Q., Liao, X., Wang, X., Qu, Z.-S., & Wang, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.073 · Cited by 26
Mack, T. G. A., Dayanandan, R., van Slegtenhorst, M., Whone, A. L., Hutton, M. L., Lovestone, S., & Anderton, B. H. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00434-1 · Cited by 26
Metadata
- Authors
- Merrick, S. E., Trojanowski, J. Q., & Lee, V. M.-Y.
- Affiliations
- University of Pennsylvania (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1997-08-01
- Volume
- 17
- Issue
- 15
- Pages
- 5726-5737
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6573204
- OpenAlex
- W1674770932
- Semantic Scholar
- ac79a6d58482597051dd8a2a3f551f09044640f7
- Cited by
- 143
- References
- 62
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 7 · 2015: 1 · 2014: 4 · 2013: 4 · 2012: 4
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, paired helical filaments, tau phosphorylation, protein phosphatase 2A, protein phosphatase 1, okadaic acid, calyculin A, microtubule depolymerization, axonal degeneration
- MeSH terms
- Axons, Enzyme Inhibitors, Humans, Marine Toxins, Microtubules, Neurons, Oxazoles, Serine, Threonine, Tumor Cells, Cultured, Okadaic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review